Marksans Pharma Limited has informed the Exchange about press release dated 21-Jul-2022 titled US FDA approval for Pregabalin Capsules, 25 mg, 50 mg,75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg ANDA.
Press Release Jul 21 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Earlier from Marksans Pharma
- Press Release Jun 21 2022
- Press Release Apr 25 2022
- Press Release Feb 22 2022
- Press Release Jan 11 2022
- Press Release Dec 09 2021
Later from Marksans Pharma
- Press Release Aug 13 2022
- Press Release Oct 11 2022
- Press Release Nov 14 2022
- Marksans Pharma Limited Press Release Jan 20 2023
- Press Release Jan 23 2023
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma